
Tilray Brands, Inc. (TLRY) – Is TLRY poised for decline?
in Company Report , Healthcare & Life Sciences , Pharma & Biotech on September 12, 2022This report is useful for M&A and business & investment analysis to all students, researchers, investors, private equity houses, broking firms, hedge funds, advisory firms and corporates to decide upon their investment strategies. Do connect with us, if you are looking for insights on any specific sector/industry and market recommendations.
Tilray Brands, Inc. (TLRY)
The cannabis market is not fully legalized in many countries around the world and this process is further
delayed due to COVID. Tilray planned for its launch of products in Europe, and other countries around the world.
Highlights
Valuation
– Enterprise Value
– CrispIdea Forecast
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum
Actual & Historical Performance
– Income Statement
– Balance Sheet– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Segment Performance
– M&A Deals
Peer Performance
– Summary
– Profitability
– Price Performance
Ownership
Stock Price Performance
Crispidea Coverage
No of Pages : 27